stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Net margin
Neogen Corporation's net margin over the twelve months to 31 August 2026 was −6.35%, down 5.4 percentage points from fiscal 2026 (−0.91%). Over the past ten years it has ranged from −122.1% (fiscal 2025) to 15.9% (fiscal 2018); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of −14.5% and below the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2026 | −0.91% | 121.14 |
| FY2025 | −122.1% | (121.03) |
| FY2024 | −1.02% | 1.76 |
| FY2023 | −2.78% | (11.94) |
| FY2022 | 9.16% | (3.84) |
| FY2021 | 13.0% | (1.22) |
| FY2020 | 14.2% | (0.31) |
| FY2019 | 14.5% | (1.34) |
| FY2018 | 15.9% | 3.65 |
| FY2017 | 12.2% | 0.84 |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Aug 2026 | −5.34% | (0.34) |
| May 2026 | −5.00% | 3.05 |
| Feb 2026 | −8.05% | (0.96) |
| Nov 2025 | −7.09% | (24.44) |
| 43 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| TMDX TransMedics Group, Inc. compare | 19.9% |
| UFPT UFP Technologies, Inc. compare | 11.8% |
| INSP Inspire Medical Systems, Inc. compare | 11.4% |
| ITGR Integer Holdings Corporation compare | 5.68% |
| NEOG Neogen Corporation | −6.35% |
| AXGN AxoGen, Inc. compare | −12.0% |
| ESTA Establishment Labs Holdings Inc. compare | −15.8% |
| BFLY Butterfly Network, Inc. compare | −43.6% |
| ALMR Alamar Biosciences, Inc. compare | −52.2% |
| Medical Devices industry median | −14.5% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement